Biosimilars have saved patients billions of dollars and are changing the treatment landscape. Here’s how.
This article is sponsored by Sandoz, a Novartis division, and global leader in generic pharmaceuticals and biosimilars.
When I started working in the health care industry over 25 years ago, I was compelled by a passion to make a difference and improve the lives of those around me. Ultimately, that mission …
